CARMOFUR

Carmofur is a 5‑FU derivative inhibiting DNA synthesis, used in oncology. Side effects include GI upset, myelosuppression, and skin reactions.

SKU: 62781333321b Category: Tag:

Product Description


Mechanism of action

Carmofur is a lipophilic fluoropyrimidine derivative and prodrug of 5‑fluorouracil (5‑FU). It inhibits thymidylate synthase, depleting dTMP required for DNA synthesis, and incorporates into RNA to disrupt transcription. Carmofur also inhibits acid ceramidase, accumulating ceramide and inducing apoptosis through sphingolipid‑mediated pathways.

Benefits and advantages

Used in anticancer research, fluoropyrimidine‑pathway studies, thymidylate‑synthase inhibition assays, sphingolipid‑signalling research, apoptosis modelling, colorectal‑cancer studies and chemoresistance analysis.

Side effects and risks

Risks include myelosuppression, diarrhoea, mucositis, hepatotoxicity, neurotoxicity and dermatologic reactions. Handle with cytotoxic‑compound containment.

Datasheet


Molecular Formula

C11H15FN2O3

Molecular Weight

257.26 g/mol

CAS Number

61422-45-5

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

carmofur; 61422-45-5; Mifurol; HCFU; 1-Hexylcarbamoyl-5-fluorouracil

IUPAC/Chemical Name

5-fluoro-N-hexyl-2,4-dioxopyrimidine-1-carboxamide

InChl Key

AOCCBINRVIKJHY-UHFFFAOYSA-N

InChl Code

InChI=1S/C11H16FN3O3/c1-2-3-4-5-6-13-10(17)15-7-8(12)9(16)14-11(15)18/h7H,2-6H2,1H3,(H,13,17)(H,14,16,18)

References

https://pubchem.ncbi.nlm.nih.gov/compound/2577;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download